Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Hematologic Oncology

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Hematologic Oncology

EHA 2019: New Macrophage Immune Checkpoint Strategy Shows Promise in AML and MDS

Hu5F9-G4 (5F9), a first-in-class antibody targeting CD47, used as monotherapy or in combination with standard azacitidine was well tolerated and provided deep and durable responses in patients with acute myeloid leukemia or myelodysplastic syndrome, according...
Read More >>

EHA 2019: Second-Generation FLT3 Inhibitors Are Future of Relapsed/Refractory FLT3-Mutant AML Treatment

EHA 2019: Imetelstat Provides Durable Transfusion Independence in Lower-Risk Relapsed/Refractory MDS

EHA 2019: Elotuzumab Triplet Continues to Show Survival Benefit in Relapsed/Refractory Myeloma

Innovation Fuels Survival Gains in Multiple Myeloma

Attaining MRD Among Next Steps in the ALL Paradigm

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

Dr. Sweetenham on Unanswered Questions With CAR T-Cell Therapy in Pediatric ALL

Dr. Runaas on Impactful Targeted Therapies in FLT3-Positive AML

Dr. Dhakal on Early Data With BiTEs in Multiple Myeloma

Dr. Winer Discusses the FDA Approval of Ivosidenib in AML

Dr. Bianchi on Shifting Landscape of Transplant Eligible Myeloma

Dr. Nadeem on Sequencing Considerations in Multiple Myeloma

Dr. Mullighan on Germline Predisposition to ALL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Acute Lymphocytic Leukemia: What's Next

Examining the Toxicities of CAR T-cell Therapy

Future Treatment Strategies in Adult ALL

Insight on Advances in the Treatment of AML

Evaluating CAR T Therapy in Acute Lymphoblastic Leukemia

OncLive houses thousands of videos that provide updates and information.
See more Videos

Using BTK Inhibitors in Community Practice

BTK Combination Strategies for B-Cell Malignancies

BTK Inhibitors in Chronic Lymphocytic Leukemia

New and Emerging BTK Inhibitors in Mantle Cell Lymphoma

First-Generation BTK Inhibition in Mantle Cell Lymphoma

BTK Inhibitors in Waldenstrom Macroglobulinemia

Genomic Profiling in Chronic Lymphocytic Leukemia

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology

Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma. View Now

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

OncLive News Network On Location: In Chicago